These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6320274)

  • 21. Vasopressin receptor-adenylate cyclase interactions. Studies in an intact cultured renal epithelial cell line (LLC-PK1).
    Skorecki KL; Verkman AS; Ausiello DA
    Miner Electrolyte Metab; 1986; 12(1):64-70. PubMed ID: 3007962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric analogues of vasopressin and bradykinin.
    Howl J; Mondszein R; Yarwood N; Wheatley M
    Biochem Soc Trans; 1997 Aug; 25(3):432S. PubMed ID: 9388656
    [No Abstract]   [Full Text] [Related]  

  • 23. [ADH and cAMP receptor binding in the kidney medulla of mice insensitive to ADH].
    Solenov EI; Zelenina MN; Ivanova LN
    Fiziol Zh SSSR Im I M Sechenova; 1991 May; 77(5):85-91. PubMed ID: 1666385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho.
    Tamma G; Wiesner B; Furkert J; Hahm D; Oksche A; Schaefer M; Valenti G; Rosenthal W; Klussmann E
    J Cell Sci; 2003 Aug; 116(Pt 16):3285-94. PubMed ID: 12829746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of (8-lysine) vasopressin binding sites on a pig kidney cell line (LLC-PK1). Evidence for hormone-induced receptor transition.
    Roy C; Ausiello DA
    J Biol Chem; 1981 Apr; 256(7):3415-22. PubMed ID: 6259166
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of vasopressin receptors in liver, but not in kidney, of ob/ob mice.
    Assimacopoulos-Jeannet F; Cantau B; van de Werve G; Jard S; Jeanrenaud B
    Biochem J; 1983 Nov; 216(2):475-80. PubMed ID: 6318739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors.
    Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH
    Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solubilization of ligand-stabilized vasopressin receptors from plasma membranes of bovine kidney and rat liver.
    Boer R; Crause P; Fahrenholz F
    Biochem Biophys Res Commun; 1983 Oct; 116(1):91-8. PubMed ID: 6315012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin antagonist analogs modified at position 7.
    Moore ML; Greene H; Huffman WF; Stassen F; Stefankiewicz J; Sulat L; Heckman G; Schmidt D; Kinter L; McDonald J
    Int J Pept Protein Res; 1986 Oct; 28(4):379-85. PubMed ID: 2947871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms.
    Andrés M; Peña A; Derick S; Raufaste D; Trojnar J; Wisniewski K; Trueba M; Serradeil-Le Gal C; Guillon G
    Eur J Pharmacol; 2004 Oct; 501(1-3):59-69. PubMed ID: 15464063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent antagonists of vasopressin antidiuretic activity that lack the beta,beta-cyclopentamethylene-beta-mercaptopropionic acid substitution at position 1.
    Yim NC; Moore ML; Huffman WF; Bryan HG; Chang HL; Kinter LB; Edwards R; Stassen FL; Schmidt D; Heckman G
    J Med Chem; 1986 Dec; 29(12):2425-6. PubMed ID: 2946863
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vasopressin and receptor].
    Marumo F
    Nihon Rinsho; 1981 Sep; 39(9):2970-4. PubMed ID: 6279927
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormone-stimulated metabolism of inositol lipids and its relationship to hepatic receptor function.
    Kirk CJ; Creba JA; Downes CP; Michell RH
    Biochem Soc Trans; 1981 Oct; 9(5):377-9. PubMed ID: 6269920
    [No Abstract]   [Full Text] [Related]  

  • 34. In the rat kidney the specific oxytocin binding sites have different selectivity for vasopressin in the cortex and the medulla.
    Arpin-Bott MP; Waltisperger E; Freund-Mercier MJ; Stoeckel ME
    Adv Exp Med Biol; 1995; 395():351-2. PubMed ID: 8713989
    [No Abstract]   [Full Text] [Related]  

  • 35. Do vasopressin receptors have a significant role in the hormonal regulation of human liver function?
    Howl J; Ismail T; Strain A; Wheatley M
    Biochem Soc Trans; 1990 Jun; 18(3):399-400. PubMed ID: 2142649
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements.
    Brooks DP; Koster PF; Albrightson CR; Huffman WF; Moore ML; Stassen FL; Schmidt DB; Kinter LB
    Eur J Pharmacol; 1989 Jan; 160(1):159-62. PubMed ID: 2540987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of a phosphomannosyl receptor from bovine liver membranes.
    Mitchell DC; Sahagian GG; Distler JJ; Wagner RM; Jourdian GW
    Methods Enzymol; 1983; 98():304-9. PubMed ID: 6321904
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the developmental patterns of vasopressin, glucagon and alpha-adrenergic receptors from rat-liver membranes.
    Butlen D; Guillon G; Cantau B; Jard S
    Mol Cell Endocrinol; 1980 Sep; 19(3):275-89. PubMed ID: 6105983
    [No Abstract]   [Full Text] [Related]  

  • 39. USP10: the nexus between nexin and vasopressin.
    Butterworth MB; Johnson JP
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F888. PubMed ID: 18667480
    [No Abstract]   [Full Text] [Related]  

  • 40. The receptor concept: prejudice, prediction, and paradox.
    Hechter O
    Adv Exp Med Biol; 1978; 96():1-43. PubMed ID: 205115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.